|(19)||(11)||EP 3 640 375 A3|
|(12)||EUROPEAN PATENT APPLICATION|
|(88)||Date of publication A3: |
|29.07.2020 Bulletin 2020/31|
|(43)||Date of publication A2: |
|22.04.2020 Bulletin 2020/17|
|(22)||Date of filing: 05.12.2013|
|(51)||International Patent Classification (IPC): |
|(84)||Designated Contracting States: |
|AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR |
|(30)||Priority: ||11.12.2012 US 201261735791 P|
11.06.2013 US 201361833588 P
|(62)||Application number of the earlier application in accordance with Art. 76 EPC: |
|13862361.6 / 2931949|
|(71)||Applicant: Albert Einstein College of Medicine|
|Bronx, NY 10461 (US)|
- ALMO, Steven, C.
Pelham, NY 10803 (US)
- SEIDEL, Ronald, D., III
Larchmont, NY 10538 (US)
- HILLERICH, Brandan, S.
Belmont, MA 02478 (US)
- GARRETT-THOMSON, Sarah, C.
New York, NY 10034 (US)
- LOVE, James, D.
|(74)||Representative: Mewburn Ellis LLP |
Bristol BS1 6BX
Bristol BS1 6BX (GB)
| || |
|(54)||METHODS FOR HIGH THROUGHPUT RECEPTOR/LIGAND IDENTIFICATION|(57)
Methods and systems for high-throughput Identification of receptor: ligand interactions are provided. Throughout this application various publications are referred to in parentheses. Full citations for these references may be found at the end of the specification. The disclosures of these publications, and all patents, patent application publications and books referred to herein, are hereby incorporated by reference in their entirety into the subject application to more fully describe the art to which the subject invention pertains.